Venclexta Shortage Update: What Patients Need to Know in 2026

Venclexta in 2026: Is There a Shortage?

If you've had trouble getting your Venclexta (Venetoclax) prescription filled, you're probably wondering: is there an actual shortage? The answer is complicated — and that's part of the problem.

As of early 2026, Venclexta is not listed on the FDA's official drug shortage database. That means there isn't a formal, nationwide supply shortage like you might see with certain generic medications. But that doesn't mean it's easy to get.

Many patients report significant delays in accessing Venclexta due to its specialty pharmacy distribution model, insurance prior authorization requirements, and high cost. These aren't "shortage" problems in the traditional sense — they're access barriers that feel just as frustrating when you're the one waiting for your cancer medication.

Is Venclexta Still Hard to Find?

Yes, for many patients. Here's why:

Specialty Pharmacy Distribution

Venclexta isn't available at your local retail pharmacy. It's distributed through specialty pharmacies — a limited network of pharmacies equipped to handle expensive, complex medications. This means you can't just walk into a CVS or Walgreens and pick it up.

If your insurer's preferred specialty pharmacy doesn't have it in stock, or if there's a processing delay, you could be waiting days or weeks.

Prior Authorization Delays

Nearly every insurance plan in the U.S. requires prior authorization for Venclexta. Your oncologist's office has to submit documentation proving you meet the coverage criteria. This can take anywhere from a few days to several weeks, and if the initial request is denied, the appeals process adds even more time.

High Cost as a Barrier

Venclexta's price — roughly $15,000 to $16,000 per month for the standard 400 mg daily dose — creates real access issues. Even with insurance, patients on specialty-tier plans may face copays of hundreds or thousands of dollars. Some patients delay filling their prescriptions while trying to sort out financial assistance.

For a detailed look at why this drug is so hard to get, read our explainer on why Venclexta is so hard to find in 2026.

How Much Does Venclexta Cost in 2026?

Here's a breakdown of current Venclexta pricing:

• 100 mg tablet: approximately $131 to $139 per tablet
• Monthly supply (400 mg/day, 120 tablets): approximately $15,000 to $16,000
• Starter pack (5-week ramp-up kit): approximately $3,400
• Annual cost: approximately $180,000 to $192,000 without insurance

There is no generic version of Venclexta available as of 2026, which keeps the price high. However, financial assistance programs can dramatically reduce what you actually pay. See our full guide on how to save money on Venclexta.

Are There New Treatment Options in 2026?

The treatment landscape for CLL, SLL, and AML continues to evolve. A few notable developments:

Venclexta + Acalabrutinib Combination

AbbVie submitted a supplemental New Drug Application (sNDA) to the FDA for the combination of Venclexta with Acalabrutinib (Calquence) for previously untreated CLL patients. The AMPLIFY trial showed 77% of patients were progression-free at three years with this all-oral, fixed-duration regimen. If approved, this gives patients another combination option.

BTK Inhibitor Alternatives

If you can't access Venclexta, several BTK inhibitors remain strong alternatives for CLL/SLL treatment:

• Ibrutinib (Imbruvica)
• Acalabrutinib (Calquence)
• Zanubrutinib (Brukinsa)
• Pirtobrutinib (Jaypirca) — for relapsed/refractory cases

Learn more about these options in our guide on alternatives to Venclexta.

How to Find Venclexta in Stock Right Now

If you need Venclexta and you need it now, here's your action plan:

1. Search on Medfinder

Use Medfinder to check which pharmacies near you have Venclexta in stock. It's faster than calling around and gives you real-time information.

2. Contact VENCLEXTA Access Solutions

The manufacturer-run program can help navigate insurance hurdles, connect you with a specialty pharmacy, and find financial assistance. Your oncologist's office can enroll you, or visit genentech-access.com.

3. Ask About Expedited Prior Authorization

If your medical situation is urgent, your doctor can request an expedited review from your insurance company. This can cut the approval timeline from weeks to days.

4. Explore Financial Assistance

Don't let cost be the reason you go without treatment:

• Genentech Oncology Co-pay Assistance Program: Eligible commercially insured patients may pay $0. Call 855-692-6729.
• Genentech Patient Foundation: Free Venclexta for eligible uninsured patients.
• HealthWell Foundation: Additional copay support for eligible patients.

For step-by-step instructions, see how to find Venclexta in stock near you.

Final Thoughts

While Venclexta isn't in a formal shortage in 2026, the real-world experience of trying to get it can feel like one. Specialty pharmacy requirements, prior authorization delays, and a price tag of $15,000+ per month create significant hurdles for patients who need this medication.

The best approach is to be proactive: start the insurance process early, use tools like Medfinder to find availability, and take advantage of every financial assistance program available to you.

You're dealing with enough. Getting your medication shouldn't be this hard — but with the right tools and information, you can navigate the system and get what you need.

More resources:

• Venclexta side effects: what to expect and when to call your doctor
• How to find a doctor who can prescribe Venclexta near you
• Venclexta drug interactions: what to avoid